The Invesco Golden Dragon China ETF targets only US-listed Chinese stocks, offering liquidity and transparency but exposing investors to lagged market reactions and potential delisting risks. We elaborate on how PGJ comes across as inferior to the more popular MCHI. With weak consumer conditions (50% of this portfolio is exposed to the discretionary sector), unappealing valuations, and lack of technical momentum, PGJ is not a buy.
The Invesco Golden Dragon China ETF stands out right with its over 20% returns YTD, ahead of the Shanghai Composite and the S&P 500. Despite this, it's hard to fully get behind the PGJ story right now, as tariff flip-flops between the U.S. and China create uncertainty. Additionally, the Chinese economy continues to struggle, which can cast a shadow on the impressive growth in the technology sector.
As the U.S. wrestles China for AI dominance, investors are playing both sides.
Count stocks from China among this year's international standouts. Widely observed gauges of equities in the world's second-largest economy are outpacing both the S&P 500 and the MSCI Emerging Markets Index by comfortable margins since the start of this year.
A looming trade deal between the U.S. and China is bullish for the Chinese stock market. When Invesco Golden Dragon China ETF is compared to iShares China Large-Cap ETF, FXI appears to be a better choice. Seeking Alpha ETF Grades highlight the differences between PGJ and FXI.
Invesco Golden Dragon China ETF has underperformed with a volatile history and an annualized total return of only 4.7% since inception. PGJ is heavily concentrated in consumer discretionary stocks, making it highly sensitive to economic cycles and vulnerable during downturns. China's long-term structural challenges, including population decline, high household debt, and a housing market bubble burst, will likely hinder PGJ's future performance.
Chinese stocks appear undervalued and could offer diversification from US markets, which are currently priced for perfection. Valuations in China are much lower compared to the US, making it a contrarian buy, especially during periods of negative sentiment. Invesco Golden Dragon China ETF is holding mostly ADRs from technology companies, which comes with additional risks, which I am not comfortable with.